International Journal of Clinical Practice · 1996 · 26 citations · 33 references
MedicineOncologyUrologyEndocrine OncologyProstate DiseaseUrologic OncologyAndrogen TherapyHormonal Cancer TherapyHormonal TherapyMetastatic Disease TreatmentProstate CancerRadical ProstatectomyAdvanced Prostate Cancer TherapyAndrogen PharmacologyEconomic Burden Of DiseaseEconomic Burden Of IllnessLuteinizing Hormone-releasing Hormone Analog TherapyMetastatic Disease PalliationProstate Cancer Hormonal TherapyProstate Cancer Hormone Therapy
SUMMARY Prostate cancer is a 20th century seedling which, because of its attendant morbidity and mortality and the increased longevity of the population, is set to germinate into a substantial economic burden in the next millennium. Most patients with prostatic cancer present with either locally advanced or metastatic disease, for which palliative endocrine therapies are the first‐line treatment. The increasingly sophisticated and selective hormonal methods available today, such as the longer‐acting formulations of luteinizing hormone‐releasing hormone (LH‐RH) analogues and newer, better‐tolerated, once‐daily, non‐steroidal anti‐androgens, have increased the therapeutic options and improved patient quality of life. Maximum androgen blockade, combining medical or surgical castration with an anti‐androgen, is an increasingly accepted therapy, and offers the greatest efficacy, particularly for patients with a lesser disease burden. The development of hormone‐refractory tumours is still a problem in advanced prostate cancer, although elucidation of the mechanisms involved should offer many potentially fruitful avenues for new therapies.
33
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
Noel Weidner, Peter R. Carroll, Jonathan Flax et al. · PubMed · 1993 · 1.6K citations
Medicine, Cancer Biology, Oncology +14
C. C. Boring, T. S. Squires, T. Tong et al. · CA A Cancer Journal for Clinicians · 1994 · 1.3K citations · Full text
Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism
Stefan Andersson, David M. Berman, Elizabeth P. Jenkins et al. · Nature · 1991 · 642 citations
Cancer in the European community and its member states
Ole Møller Jensen, Jaques Esteve, Henrik Møller et al. · European Journal of Cancer and Clinical Oncology · 1990 · 463 citations
Medicine, Oncology, Cancer Control +13